Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy
- E. Nicastri, C. Angeletti, +5 authors S. Vella
- Medicine
- AIDS
- 24 March 2005
Objective: To assess gender differences in the long-term clinical, virological and immunological outcomes during highly active antiretroviral therapy (HAART). Methods: This longitudinal observational… Expand
Clinical outcome after 4 years follow‐up of HIV‐seropositive subjects with incomplete virologic or immunologic response to HAART
- E. Nicastri, A. Chiesi, +5 authors S. Vella
- Medicine
- Journal of medical virology
- 1 June 2005
The duration of the clinical, virologic, and immunologic response to HAART, is not well defined. In this observational multi‐center study 2,143 patients were enrolled classified according to… Expand
Primary human herpesvirus 8 infection in immunocompetent children.
- M. Andreoni, L. Sarmati, +6 authors G. Rezza
- Medicine
- JAMA
- 13 March 2002
CONTEXT
Human herpesvirus 8 (HHV-8) infection causes Kaposi sarcoma and lymphoproliferative disorders in immunosuppressed adults. Its manifestations in immunocompetent hosts are unknown.
OBJECTIVES… Expand
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.
- P. Di Bartolomeo, S. Santarone, +16 authors W. Arcese
- Medicine
- Blood
- 31 January 2013
UNLABELLED
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM transplantation from an haploidentical family donor. Patients were transplanted in first or… Expand
Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy
- S. Babudieri, B. Longo, +18 authors G. Rezza
- Medicine
- Journal of medical virology
- 1 July 2005
A cross‐sectional study was undertaken on the correlates of infection for the human immunodeficiency virus (HIV) and hepatitis viruses B and C (HBV and HCV) in a sample of inmates from eight Italian… Expand
Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors
- F. Ceccherini-Silberstein, K. Van Baelen, +14 authors C. Perno
- Biology, Medicine
- Antimicrobial Agents and Chemotherapy
- 17 May 2010
ABSTRACT The goal of this study was to explore the presence of integrase strand transfer inhibitor (InSTI) resistance mutations in HIV-1 quasispecies present in InSTI-naïve patients and to evaluate… Expand
HHV-8 infection in African children.
- L. Sarmati
- Medicine
- Herpes : the journal of the IHMF
- 1 August 2004
Human herpesvirus 8 (HHV-8) is prevalent in Africa and parts of southern Europe, but less common elsewhere. It is analogous to its distant relative, the Epstein-Barr virus, in that it rarely causes… Expand
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression
- R. Salpini, L. Colagrossi, +24 authors V. Svicher
- Medicine
- Hepatology
- 1 March 2015
Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated hepatitis B surface antigen (HBsAg) genetic… Expand
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
- C. Liguori, M. Pierantozzi, +12 authors N. Mercuri
- Medicine
- Brain, Behavior, and Immunity
- 13 May 2020
Abstract
Objective
Coronavirus disease 2019 (COVID-19) represents a novel pneumonia leading to severe acute respiratory syndrome… Expand
Characterization of drug resistance mutations in naïve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon
- L. Ceccarelli, R. Salpini, +12 authors G. Cappelli
- Medicine
- Journal of medical virology
- 1 May 2012
Currently the prevalence of HIV‐1 infection in Cameroon is 5.1%, CRF02_AG subtype is responsible for about 50% of infections. Since an HIV‐1 drug resistance test is not yet available widely, accurate… Expand